Literature DB >> 26836700

Primary High-Grade Osteosarcoma of the Clivus: A Case Report and Literature Review.

Mansour Mathkour1, Juanita Garces2, Bryce Beard3, Angela Bartholomew4, Olawale A R Sulaiman4, Marcus L Ware4.   

Abstract

BACKGROUND: Osteosarcoma is the second most common primary tumor of the skeletal system and the most common primary bone tumor. Usually occurring at the metaphysis of long bones, osteosarcomas are highly aggressive lesions that comprise osteoid-producing spindle cells. Craniofacial osteosarcomas comprise <8% and are believed to be less aggressive and lower grade. Primary osteosarcomas of the skull and skull base comprise <2% of all skull tumors. Osteosarcomas originating from the clivus are rare. We present a case of a primar, high-grade clival osteosarcoma. CASE DESCRIPTION: A 29-year-old man presented to our institution with a progressively worsening right frontal headache for 3 weeks. There were no sensory or cranial nerve deficits. Computed tomography revealed a destructive mass involving the clivus with extension into the left sphenoid sinus. Magnetic resonance imaging revealed a homogenously enhancing lesion measuring 2.7 × 2.5 × 3.2 cm. The patient underwent endonasal transphenoidal surgery for gross total resection. The histopathologic analysis revealed proliferation of malignant-appearing spindled and epithelioid cells with associated osteoclast-like giant cells and a small area of osteoid production. The analysis was consistent with high-grade osteosarcoma. The patient did well and was discharged on postoperative day 2. He was referred for adjuvant radiation therapy and chemotherapy. Two-year follow-up showed postoperative changes and clival expansion caused by packing material.
CONCLUSIONS: Osteosarcoma is a highly malignant neoplasm. These lesions are usually found in the extremities; however, they may rarely present in the craniofacial region. Clival osteosarcomas are relatively infrequent. We present a case of a primary clival osteosarcoma with high-grade pathology.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clival osteosarcoma; Endonasal transphenoidal approach; Primary high-grade osteosarcoma; Sellar osteosarcoma; Skull base osteosarcoma

Mesh:

Year:  2016        PMID: 26836700     DOI: 10.1016/j.wneu.2016.01.054

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  9 in total

1.  Extracellular vesicles from bone mesenchymal stem cells transport microRNA-206 into osteosarcoma cells and target NRSN2 to block the ERK1/2-Bcl-xL signaling pathway.

Authors:  Alimu Keremu; Pazila Aila; Aikebaier Tusun; Maimaitiaili Abulikemu; Xiaoguang Zou
Journal:  Eur J Histochem       Date:  2022-06-22       Impact factor: 1.966

2.  CT and MRI features of calvarium and skull base osteosarcoma (CSBO).

Authors:  Zhendong Luo; Weiguo Chen; Xinping Shen; Genggeng Qin; Jianxiang Yuan; Biying Hu; Jianxun Lyu; Derun Pan
Journal:  Br J Radiol       Date:  2019-11-28       Impact factor: 3.039

Review 3.  Primary and radiation induced skull base osteosarcoma: a systematic review of clinical features and treatment outcomes.

Authors:  Othman Bin Alamer; Ali S Haider; Maryam Haider; Navraj S Sagoo; Faith C Robertson; Eliel N Arrey; Salah G Aoun; Kenny Yu; Aaron A Cohen-Gadol; Tarek Y El Ahmadieh
Journal:  J Neurooncol       Date:  2021-05-17       Impact factor: 4.506

Review 4.  Primary osteogenic sarcoma of the skull: Report of two cases with review of literature.

Authors:  R Singh; K Jha; I Pant; D Satti
Journal:  J Postgrad Med       Date:  2018 Oct-Dec       Impact factor: 1.476

5.  Long noncoding RNA BSN-AS2 induced by E2F1 promotes spinal osteosarcoma progression by targeting miR-654-3p/SYTL2 axis.

Authors:  Xianwei Zhou; Jitian Li; Junyan Teng; Yufeng Liu; Di Zhang; Linyun Liu; Wenming Zhang
Journal:  Cancer Cell Int       Date:  2020-04-25       Impact factor: 5.722

6.  MicroRNA-520b Suppresses Proliferation, Migration, and Invasion of Spinal Osteosarcoma Cells via Downregulation of Frizzled-8.

Authors:  Jin Wang; Wenquan Pang; Zhenbai Zuo; Wenyan Zhang; Weidong He
Journal:  Oncol Res       Date:  2017-02-28       Impact factor: 5.574

Review 7.  Primary osteosarcoma of frontal bone: A case report and review of literature.

Authors:  Guangyong Wu; Qi Liang; Yu Liu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

8.  Bone morphogenetic protein and activin membrane-bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF-β-induced EMT signaling pathway.

Authors:  Fengsong Liu; Kai Wang; Liang Zhang; Ya-Lin Yang
Journal:  Oncol Lett       Date:  2018-08-06       Impact factor: 2.967

9.  Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.

Authors:  Longqiang Zhang; Guangzong Zhao; Shaolin Ji; Qihua Yuan; Haiyan Zhou
Journal:  Med Sci Monit       Date:  2020-03-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.